Oracle's 56% decline from September peak has created a significant mean reversion opportunity as the stock trades at valuation levels where the core software business alone justifies the entire market cap, making OCI expansion 'pure upside.' With securities fraud litigation timelines now defined (April 6 lead plaintiff deadline) and $45-50B financing plan removing capital uncertainty, the worst-case scenarios appear priced in at $149.25 while positive catalysts including analyst upgrades and strategic partnerships provide near-term support for a technical bounce toward $170-180.